Fred Alger Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Fred Alger Management, LLC

  • $20.1 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$27.51 - $57.29 $385,140 - $802,060
-14,000 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$40.86 - $57.65 $163,440 - $230,600
-4,000 Reduced 22.22%
14,000 $762,000
Q3 2019

Nov 14, 2019
SELL
$37.38 - $49.47 $74,760 - $98,940
-2,000 Reduced 10.0%
18,000 $751,000
Q2 2019

Aug 14, 2019
BUY
$39.79 - $67.01 $795,800 - $1.34 Million
20,000 New
20,000 $876,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email